Develops small, stable, highly engineerable scaffold-protein affinity ligands for GMP downstream purification and as biopharmaceutical binders for pharma, biotech and life sciences companies. Platforms: PRECISION CAPTURING—Fc‑independent, antibody‑like ligands for purifying mAbs, recombinant proteins, viruses/VLPs and cells with GMP-ready affinity resins; PRECISION TARGETING—ubiquitin‑based Affilin® ligands for targeted therapeutics and diagnostics (radiopharmaceuticals, protein‑drug conjugates, CAR‑T ligands, theranostics).